Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015-2019
posted on 2020-05-28, 08:04authored byHee Soo Kim, Yongho Oh, Joanna Korejwo, Valérie Bosch Castells, Kuhyun Yang
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).